Results 11 to 20 of about 101,964 (348)
Frontiers in Endocrinology, 2020 Calcitonin is a small peptide hormone secreted from the parafollicular cells of the thyroid gland in response to an increase in serum calcium. The inhibition of osteoclastic resorption is the main mechanism by which calcitonin quickly decreases ...
Chen-Yuan Hsiao +11 more
doaj +2 more sources
Calcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations
International Journal of Endocrinology, 2020 Calcitonin was discovered as a peptide hormone that was known to reduce the calcium levels in the systemic circulation. This hypocalcemic effect is produced due to multiple reasons such as inhibition of bone resorption or suppression of calcium release ...
Jingbo Xie +9 more
doaj +2 more sources
Beyond CGRP: The calcitonin peptide family as targets for migraine and pain
British Journal of Pharmacology, 2021 The CGRP system has emerged as a key pharmacological target for the treatment of migraine. However, some individuals who suffer from migraine have low or no response to anti‐CGRP or other treatments, suggesting the need for additional clinical targets ...
Tayla A. Rees +3 more
semanticscholar +1 more source
Environmental Factors That Affect Parathyroid Hormone and Calcitonin Levels
International Journal of Molecular Sciences, 2021 Calciotropic hormones, parathyroid hormone (PTH) and calcitonin are involved in the regulation of bone mineral metabolism and maintenance of calcium and phosphate homeostasis in the body.
Mirjana Babić Leko +3 more
semanticscholar +1 more source
Sexual dimorphism in relationships between of plasma bilirubin and some neuro-endocrine parameters
Journal of Education, Health and Sport, 2022 Background. Earlier we found that plasma uric acid, urea and creatinine causes modulating effects on neuro-endocrine parameters, as well as anxiety, but these effects are significantly different in men and women of different ages.
Walery Zukow +3 more
doaj +1 more source
BMC Research Notes, 2019 Objective Calcitonin is considered to be a biomarker of medullary thyroid carcinoma and C-cell hyperplasia, but calcitonin can also be elevated in about 30% of the patients with end-stage kidney disease.
Roza Sabia +6 more
doaj +1 more source
Revista Colombiana de Endocrinología, Diabetes y Metabolismo, 2017 Objective: medullary thyroid carcinoma (MTC) with normal serum basal calcitonin (calcitonin-negative MTC) is uncommon. The exact mechanism for this paradox is unclear.
John J. Orrego, Joseph A. Chorny
doaj +1 more source
The Journal of Headache and Pain, 2019 Background and aimMonoclonal antibodies acting on the calcitonin gene-related peptide or on its receptor are new drugs to prevent migraine. Four monoclonal antibodies have been developed: one targeting the calcitonin gene-related peptide receptor ...
S. Sacco +6 more
semanticscholar +1 more source
Serum tumor markers in thyroid diseases
Mìžnarodnij Endokrinologìčnij Žurnal, 2019 The article highlights the role of serum tumor markers in the diagnosis and treatment of thyroid diseases, primarily various forms of cancer.
R.D. Makar, V.I. Vovk, I.M. Pavlovsky
doaj +1 more source
Corrigendum: Medullary thyroid cancer. Returning to the need to determine the preoperative basal calcitonin level in patients with thyroid nodular pathology (Endocrine surgery. 2018;12(4). doi: 10.14341/serg10044) [PDF]
Эндокринная хирургия, 2019 A corrigendum on Medullary thyroid cancer. Returning to the need to determine the preoperative basal calcitonin level in patients with thyroid nodular pathology by Elena E. Stanyakina, Ilia S. Romanov, Tatiana T. Kondratieva, Alexander S.
Elena E. Stanyakina +5 more
doaj +1 more source